Douglas William Gledhill

Title: **Douglas William Gledhill: Innovator in Respiratory Treatment**

Introduction

Douglas William Gledhill is a notable inventor based in St. Charles, MO, with a remarkable portfolio that includes 10 patents. His work primarily focuses on compositions and methods for treating respiratory illnesses, showcasing significant contributions to the pharmaceutical field.

Latest Patents

Among his latest innovations, Gledhill has developed two key patents aimed at improving respiratory health. The first patent pertains to "Compositions and methods useful for treatment of respiratory illness," where he discloses compositions that include phenylephrine and its various forms. These compositions are notable for having a pH range of about 2 to about 5 and are designed to be substantially free of aldehydes. The second patent, titled "Compositions and kits useful for treatment of respiratory illness," presents a stable liquid formulation that contains a specific concentration of phenylephrine hydrochloride. This formulation is characterized by its low aldehyde content and is packaged in a clear bottle made from various suitable materials.

Career Highlights

Douglas Gledhill has established a successful career at The Procter & Gamble Company, contributing to its mission through his innovative research and development. His efforts have resulted in multiple patents that not only demonstrate his expertise but also enhance the company's product offerings in respiratory care.

Collaborations

Throughout his career, Gledhill has worked alongside skilled professionals such as Susan Elaine Criss and Niranjan Ramji. These collaborations have further enriched the collective knowledge in their field, allowing for the development of effective treatments for respiratory issues.

Conclusion

Douglas William Gledhill stands out as an influential inventor, pushing the boundaries of innovation in respiratory treatment. His dedication to improving health outcomes through scientific advancements makes him a significant figure in the pharmaceutical industry. With ongoing research and development, Gledhill's contributions will continue to shape the future of respiratory health solutions.